NCT00403156View on ClinicalTrials.gov

Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 30, 2006

Conditions

Choroidal Neovascularization

Interventions

DRUG

Imatinib Mesylate /Ranibizumab

Trial Locations (1)

10022

Vitreous Retina Macula Consultants of New York, P.C., New York

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Vitreous -Retina- Macula Consultants of New York

OTHER